Skip to content
Search

Latest Stories

EMIS Group acquires PharmOutcomes operators

EMIS Group has acquired Pinnacle Health Partnership and Pinnacle Systems Management– owners and operators of the PharmOutcomes platform.

The acquisition aims to drive widespread improvements in medicines management and to support pharmacy in providing more clinical services.


Shanel Raichura, clinical director at EMIS Health, said: “This is an exciting acquisition for EMIS Group. It will enable us to provide new services more quickly to our pharmacy customers – supporting them in their changing role.

“By joining up the technology, we will make it easier for pharmacy to deliver a wider range of patient services – including referrals from NHS 111 and from GP practices – and to fulfill the requirements of the new contract.

“There will also be the opportunity to develop new services, for example in response to the Patient Group Directions initiative.”

The deal will see PharmOutcomes become seamlessly embedded in EMIS Group’s ProScript Connect software – a leading community pharmacy system.

System improvements will also be made available to the wider marketplace and to non-EMIS Health customers, in line with EMIS Health’s commitment to interoperability.

Gary Warner and Kevin Noble, managing partners at Pinnacle Health Partnership LLP, will remain in charge post acquisition – along with their management team.

Gary Warner, who is also a practicing pharmacist on the Isle of Wight, said: “We created PharmOutcomes to help commissioners to understand and better engage with pharmacy.  Becoming part of EMIS Group will open up a host of new opportunities for us to build on our success and to further support pharmacy in its future role. It’s an exciting time.”

“We are reassuring all PharmOutcomes customers that our services will continue unchanged and the future developments will benefit EMIS Health and non-EMIS Health customers alike.”

PharmOutcomes is a web-based service management solution used by over 11,000 community pharmacies to record and manage nationally and locally commissioned patient services such as: flu vaccinations, the community pharmacist consultation service, and hospital discharge referral management.

It allows local and national level analysis and reporting on the effectiveness of commissioned services, helping to improve the evidence base for community pharmacy services.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less